A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

This groundbreaking finding, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, suggests that ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

Since its approval in 2023, the Alzheimer's disease drug made by Biogen Inc. and Eisai has seen a lackluster launch. However, ...

Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

"During the early stage, it's possible for people with dementia to live well by taking control of their health and wellness, ...

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems long and uncertain, according to a news release.